BetterLife Pharma (BETRF) Ratios
BetterLife Pharma Ratios
BETRF's free cash flow for Q2 2027 was $-1.40M. For the 2027 fiscal year, BETRF's free cash flow was increased by $0.00 and operating cash flow was $-1.40M. See a summary of the company’s cash flow.
| Ratios | Apr 26 | Apr 25 | Apr 24 | Apr 23 | Apr 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.03 | 0.03 | 0.05 | 0.01 | 0.28 |
| Quick Ratio | 0.03 | 0.03 | 0.05 | 0.01 | 0.28 |
| Cash Ratio | 0.00 | 0.00 | 0.01 | 0.00 | 0.04 |
| Solvency Ratio | -0.22 | 0.16 | -0.36 | -1.18 | -2.41 |
| Operating Cash Flow Ratio | -0.09 | -0.27 | -0.36 | -0.21 | -2.70 |
| Short-Term Operating Cash Flow Coverage | -0.71 | -2.32 | 0.00 | -2.01 | -47.09 |
| Net Current Asset Value | $ -6.49M | $ -7.36M | $ -7.70M | $ -7.53M | $ -3.90M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 4.12 | 5.79 | 4.52 | 15.89 | 1.20 |
| Debt-to-Equity Ratio | -0.09 | -0.12 | -0.14 | -0.11 | -0.36 |
| Debt-to-Capital Ratio | -0.10 | -0.14 | -0.16 | -0.12 | -0.56 |
| Long-Term Debt-to-Capital Ratio | -0.00 | -0.00 | -0.03 | -0.04 | -0.30 |
| Financial Leverage Ratio | -0.02 | -0.02 | -0.03 | -0.01 | -0.30 |
| Debt Service Coverage Ratio | -1.63 | -2.77 | -62.70 | -11.35 | -40.79 |
| Interest Coverage Ratio | -7.80 | -15.65 | -63.66 | -140.83 | -174.96 |
| Debt to Market Cap | 0.12 | 0.06 | 0.03 | 0.09 | 0.07 |
| Interest Debt Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 |
| Net Debt to EBITDA | -0.49 | -0.39 | -0.45 | -0.13 | -0.10 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 98.85% | 97.19% | 99.67% | 96.20% | 101.39% |
| EBT Per EBIT | 83.65% | 72.44% | 89.45% | 99.07% | 117.48% |
| Return on Assets (ROA) | -680.07% | -1564.83% | -889.63% | -12065.52% | -1046.97% |
| Return on Equity (ROE) | 15.28% | 32.97% | 26.73% | 84.04% | 313.31% |
| Return on Capital Employed (ROCE) | 28.00% | 68.37% | 49.83% | 133.76% | 342.34% |
| Return on Invested Capital (ROIC) | 32.40% | 82.51% | 54.44% | 167.19% | 372.02% |
| Return on Tangible Assets | -680.07% | -1564.83% | -889.63% | -12065.52% | -1046.97% |
| Earnings Yield | -20.50% | -21.86% | -29.37% | -69.44% | -78.59% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | -77964.93 | -66151.02 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 77964.93 | 66151.02 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.00 | -0.02 | -0.02 | -0.02 | -0.15 |
| Free Cash Flow Per Share | -0.00 | -0.02 | -0.02 | -0.02 | -0.15 |
| Dividend Paid and CapEx Coverage Ratio | -125091.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Capital Expenditure Coverage Ratio | -125091.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow Coverage Ratio | -0.69 | -1.55 | -1.68 | -1.27 | -8.03 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -8.57% | -12.56% | -25.14% | -11.58% | -72.41% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -4.90 | -4.58 | -3.40 | -1.44 | -1.27 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | -0.75 | -1.51 | -0.91 | -1.21 | -3.99 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -11.66 | -7.96 | -3.98 | -8.64 | -1.38 |
| Price-to-Operating Cash Flow Ratio | -11.66 | -7.96 | -3.98 | -8.64 | -1.38 |
| Price-to-Earnings Growth (PEG) Ratio | 0.08 | -0.60 | 0.05 | 0.04 | 0.01 |
| Enterprise Value Multiple | -4.53 | -5.27 | -3.53 | -1.53 | -1.40 |
| Enterprise Value | 8.19M | 17.40M | 11.27M | 14.16M | 16.69M |
| EV to EBITDA | -4.53 | -5.27 | -3.53 | -1.53 | -1.40 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -13.09 | -8.60 | -4.56 | -9.42 | -1.49 |
| EV to Operating Cash Flow | -13.09 | -8.60 | -4.56 | -9.42 | -1.49 |
| Tangible Book Value Per Share | -0.04 | -0.06 | -0.07 | -0.09 | -0.05 |
| Shareholders’ Equity Per Share | -0.07 | -0.09 | -0.10 | -0.12 | -0.05 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.01 | -0.03 | -0.03 | -0.10 | -0.16 |
| Tax Burden | 0.99 | 0.97 | 1.00 | 0.96 | 1.01 |
| Interest Burden | 0.84 | 0.77 | 0.90 | 1.01 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.41 | 0.56 | 0.86 | 0.16 | 0.92 |
Currency in CAD
